Nano-X Imaging holder plans sale of ordinary shares

A shareholder of Nano-X Imaging Ltd. (NNOX) has filed a notice of proposed sale of ordinary shares.

Rhea-AI Filing Summary

A shareholder of Nano-X Imaging Ltd. (NNOX) has filed a notice of proposed sale of ordinary shares. The filing lists ordinary shares to be sold through Etrade and Altshare, with indicated quantities of 1,000 and 5,950 shares and aggregate market values of 880.00 and 5,236.00, respectively, to be sold on Nasdaq in late July 2026.

The shareholder reports that the 1,000 shares were acquired by purchase on 09/05/2025 through Etrade as a purchase in the open market, and that 5,950 shares were acquired via an RSU Grant on 04/16/2024. These details document how the securities were obtained prior to the planned sales.

Key Figures

Shares block 1: 1,000 shares Aggregate market value block 1: 880.00 Approximate sale date block 1: 07/30/2026 +4 more

7 metrics

Shares block 1 1,000 shares Ordinary shares line associated with Etrade and Nasdaq

Aggregate market value block 1 880.00 Aggregate market value for the 1,000-share ordinary share block

Approximate sale date block 1 07/30/2026 Planned sale date for the Etrade ordinary share block

Shares block 2 5,950 shares Ordinary shares line associated with Altshare and Nasdaq

Aggregate market value block 2 5,236.00 Aggregate market value for the 5,950-share ordinary share block

Acquisition date purchase 09/05/2025 Date 1,000 shares were acquired by purchase in the open market

Acquisition date RSU Grant 04/16/2024 Date 5,950 shares were acquired via RSU Grant

Key Terms

RSU Grant, purchase in the open market, Ordinary Shares

3 terms

RSU Grant financial

"5950 | 04/16/2024 | RSU Grant | Grant"

purchase in the open market financial

"1000 | 09/05/2025 | purchase in the open market"

Ordinary Shares financial

"Ordinary Shares | Etrade 1585 Broadway New York NY 10036"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the NNOX Form 144 filing disclose about planned share sales?

The filing discloses a proposed sale of Nano-X Imaging ordinary shares. It lists 1,000 shares and 5,950 shares to be sold on Nasdaq through brokerage arrangements with Etrade and Altshare, with specified aggregate market values and planned sale dates in July 2026.

How many Nano-X Imaging (NNOX) shares are covered in this Form 144?

The document lists 1,000 ordinary shares and 5,950 ordinary shares in the securities information section. Each block includes an aggregate market value and an approximate sale date, indicating the scale and timing of the proposed sales.

When were the NNOX shares in the Form 144 originally acquired?

The shares were acquired on two dates: 09/05/2025 and 04/16/2024. The filing states that 1,000 shares were obtained by purchase in the open market via Etrade, and 5,950 shares came from an RSU Grant on April 16, 2024.

What acquisition methods are reported for the Nano-X Imaging (NNOX) shares?

Two acquisition methods are reported: a purchase in the open market and an RSU Grant. The shareholder bought 1,000 shares through Etrade on September 5, 2025, and received 5,950 shares as a grant on April 16, 2024.

On which market are the NNOX shares in this Form 144 expected to be sold?

The proposed sales are associated with the Nasdaq market. Both blocks of Nano-X Imaging ordinary shares listed in the securities information section specify Nasdaq as the securities exchange for the contemplated transactions.

Which brokers are involved in the planned NNOX share transactions in this filing?

The filing identifies Etrade and Altshare as involved in the ordinary share transactions. Etrade is tied to the 1,000-share block acquired by purchase, while Altshare appears as the address reference for the 5,950-share block.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/28/2026 - 09:38 PM Accepted by SEC EDGAR 07/28/2026 - 09:37 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001507133
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Nano-X Imaging Ltd.
SEC File Number	001-39461
Address of Issuer	OFER TECH PARK 94 SHLOMO SHMELTZER ROAD PETACH TIKVA ISRAEL 4970602
Phone	972-37359202
Name of Person for Whose Account the Securities are To Be Sold	Daniel Ran
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Member of immediate family of any of the foregoing

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Etrade 1585 Broadway New York NY 10036	1000	880.00	5950	07/30/2026	Nasdaq
Ordinary Shares	Altshare Habarzel 19, Ramat Hajayal, Tel-Aviv 69 Tel Aviv L3 6971026	5950	5236.00	0	07/29/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary shares	09/05/2025	purchase	Etrade			1000	09/05/2025	purchase in the open market
5950	04/16/2024	RSU Grant	Grant			5950	04/16/2024	Grant

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	07/28/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Ran Daniel
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)